David Michael Dombkowski

Title: David Michael Dombkowski: Innovator in Ovarian Cancer Research

Introduction

David Michael Dombkowski is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical research, particularly in the area of ovarian cancer. His innovative work focuses on the treatment, characterization, and diagnosis of ovarian cancer, which is a critical area of study given the disease's impact on women's health.

Latest Patents

Dombkowski holds a patent for "Collecting ovarian cancer stem cells from ovarian cancer cells." This invention relates to compositions and methods for treating and diagnosing ovarian cancer. The patent outlines methods for treating and preventing ovarian cancer by administering effective amounts of Mullerian Inhibiting substance and agents that inhibit BCRP1. Additionally, it provides methods to identify and enrich populations of ovarian cancer stem cells and somatic ovarian stem cells, including specific markers for these cells.

Career Highlights

David Michael Dombkowski is associated with The General Hospital Corporation, where he continues to advance his research in ovarian cancer. His work is crucial in developing new therapeutic strategies that could improve patient outcomes.

Collaborations

Dombkowski collaborates with esteemed colleagues such as David T MacLaughlin and Patricia K Donahoe. Their combined expertise enhances the research efforts in understanding and combating ovarian cancer.

Conclusion

David Michael Dombkowski's contributions to ovarian cancer research through his innovative patent demonstrate his commitment to improving medical treatments. His work is vital in the ongoing fight against this challenging disease.